Literature DB >> 26368351

Association Between Angiotensin Receptor Blockers and Longitudinal Decline in Tau in Mild Cognitive Impairment.

Ihab Hajjar1, Allan Levey2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26368351      PMCID： PMC4752362          DOI： 10.1001/jamaneurol.2015.1001

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN： 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  6 in total

1.  Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Michal Figurski; Els Coart; Kaj Blennow; Holly Soares; Adam J Simon; Piotr Lewczuk; Robert A Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2011-02-11       Impact factor: 17.088

2.  Effect of antihypertensive therapy on cognitive function in early executive cognitive impairment: a double-blind randomized clinical trial.

Authors:  Ihab Hajjar; Meaghan Hart; Yu-Ling Chen; Wendy Mack; William Milberg; Helena Chui; Lewis Lipsitz
Journal:  Arch Intern Med       Date:  2012-03-12

3.  Impact of Angiotensin receptor blockers on Alzheimer disease neuropathology in a large brain autopsy series.

Authors:  Ihab Hajjar; Lauren Brown; Wendy J Mack; Helena Chui
Journal:  Arch Neurol       Date:  2012-12

4.  Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease.

Authors:  L M Bierer; P R Hof; D P Purohit; L Carlin; J Schmeidler; K L Davis; D P Perl
Journal:  Arch Neurol       Date:  1995-01

5.  Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase.

Authors:  J Z Wang; Q Wu; A Smith; I Grundke-Iqbal; K Iqbal
Journal:  FEBS Lett       Date:  1998-09-25       Impact factor: 4.124

6.  Angiotensin II causes imbalance between pro- and anti-inflammatory cytokines by modulating GSK-3β in neuronal culture.

Authors:  Deepmala Agarwal; Rahul B Dange; Mohan K Raizada; Joseph Francis
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739
  6 in total
  9 in total

1.  Association of Antihypertensives and Cognitive Impairment in Long-Term Care Residents.

Authors:  Zachary A Marcum; Yongmei Li; Sei J Lee; Michael A Steinman; Laura Graham; Bocheng Jing; Kathy Fung; Carmen A Peralta; Michelle C Odden
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

2.  Neurofibrillary Tangles and Conversion to Mild Cognitive Impairment with Certain Antihypertensives.

Authors:  Whitney Wharton; Liping Zhao; Kyle Steenland; Felicia C Goldstein; Julie A Schneider; Lisa L Barnes; Marla Gearing; Sevil Yasar
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

3.  Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial.

Authors:  Whitney Wharton; Felicia C Goldstein; Malú G Tansey; Alexandra L Brown; Sonum D Tharwani; Danielle D Verble; Amarallys Cintron; Patrick G Kehoe
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 4.  Relationship Between Antihypertensive Medications and Cognitive Impairment: Part II. Review of Physiology and Animal Studies.

Authors:  Ruth Peters; Mattan Schuchman; Jean Peters; Michelle C Carlson; Sevil Yasar
Journal:  Curr Hypertens Rep       Date:  2016-08       Impact factor: 5.369

Review 5.  The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment?

Authors:  Patrick Gavin Kehoe
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

6.  Divergence in the activity of the N- and C- catalytic domains of ACE1 - implications for the role of the renin-angiotensin system in Alzheimer's disease.

Authors:  Noura S Al Mulhim; Patrick G Kehoe; J Scott Miners
Journal:  Acta Neuropathol Commun       Date:  2019-04-24       Impact factor: 7.801

7.  Do Patient Concerns About Antihypertensive Use For Dementia Prevention Vary By Current Use Of Antihypertensive?

Authors:  Woojung Lee; Shelly L Gray; Douglas Barthold; Paul K Crane; Eric B Larson; Zachary A Marcum
Journal:  Patient Prefer Adherence       Date:  2019-10-23       Impact factor: 2.711

8.  ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Charles E Evans; James S Miners; Giulia Piva; Christine L Willis; David M Heard; Emma J Kidd; Mark A Good; Patrick G Kehoe
Journal:  Acta Neuropathol       Date:  2020-01-25       Impact factor: 15.887

9.  Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment.

Authors:  Zachary A Marcum; Jordana B Cohen; Chong Zhang; Catherine G Derington; Tom H Greene; Lama Ghazi; Jennifer S Herrick; Jordan B King; Alfred K Cheung; Nick Bryan; Mark A Supiano; Joshua A Sonnen; William S Weintraub; Jeff Williamson; Nicholas M Pajewski; Adam P Bress
Journal:  JAMA Netw Open       Date:  2022-01-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.